2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody
2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody Detail:
Product details
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by Escherichia coli expression system and the target gene Met1-Ala419 is expressed with 6 HIS tag at the N-terminus. Consists of 428 amino acids and predicts a molecular mass of 46.6 kDa.
Properties
| Purity | ≥95% (SDS-PAGE) |
| Molecular Mass | 46.6 kDa |
| Product Buffer | 20mM PB, 150mM NaCl, 10%Glycerol, pH8.0. |
| Storage | Store at -20℃ to -80℃. Avoid multiple freeze/thaw cycles. |
Order Information
| Product Name | Cat. No | Quantity |
| Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) | AG0046 | Customized |
Product detail pictures:
Related Product Guide:
Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" as well as theory of "quality the basic, have faith in the initial and administration the advanced" for 2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody , The product will supply to all over the world, such as: Bangalore, Ottawa, Bolivia, We have been fully aware of our customer's needs. We deliver high quality products, competitive prices and the first class service. We would like to establish good business relationships as well as friendship with you in the near future.
By Geraldine from Belgium - 2018.05.13 17:00
The factory workers have rich industry knowledge and operational experience, we learned a lot in working with them,we are extremely grateful that we can encount a good company has excellent wokers.
By Nicci Hackner from Gabon - 2018.06.28 19:27
Write your message here and send it to us
